glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma Combined inhibition of de novo
Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Patientderived xenograft models in pancancer: From bench to clinic Li 2025 Interdisciplinary Medicine Wiley Online Library Patient Derived Xenografts [PDX] Page 1 Celprogen Catabolism of extracellular glutathione supplies cysteine to support tumours Nature Ferroptosis driven by nanoparticles for tackling glioblastoma ScienceDirect
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




